The performance of companies tied to Sildenafil's legacy presents a complex investment landscape. While the initial boom generated substantial returns , generic competition have significantly eroded revenue. https://kingslists.com/story23057533/the-copyright-and-the-pharmaceutical-sector-a-risky-investment